FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly
The modest benefits of the treatment, donanemab, made by Eli [...]
Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports
The company reported results of clinical trials involving Zepbound, an [...]
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs
Lawmakers raising national security concerns and seeking to disconnect a [...]
F.D.A. Delays Action on Closely Watched Alzheimer’s Drug
Eli Lilly’s donanemab was expected to be approved this month, [...]
Users of Zepbound or Mounjaro Had Lower Blood Pressure in Study
The patients used tirzepatide, sold as Mounjaro or Zepbound, but [...]
6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptions
An array of obstacles makes it difficult for patients to [...]
Eli Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealth
The maker of Zepbound and Mounjaro launched a new platform [...]
Zepbound, el nuevo medicamento aprobado por la FDA para perder peso
Este fármaco tiene el mismo compuesto que Mounjaro, el muy [...]
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovy
Zepbound, which is already sold by Eli Lilly as the [...]
FDA Approves Zepbound, A Drug Like Ozempic, for Weight Loss. Here’s What to Know.
The obesity medication contains tirzepatide, the same active ingredient in [...]